Theravance Biopharma, Inc. — Director's Dealing 2016

Nov 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Theravance Biopharma, Inc. (TBPH)
CIK: 0001583107
Period of Report: 2016-11-20

Reporting Person: HEGDE SHARATHCHANDRA S (SVP, Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-20	Ordinary Shares	F	1845	$31.96	Disposed	171628	Direct